Scientists developed a method to produce functional megakaryocytes from human induced pluripotent stem cells-derived CD34+ hematopoietic stem cells under a feeder-free and xeno-free condition and minimized the risk and variation from the animal-derived products in cell cultures.
[Journal of Pharmacology and Experimental Therapeutics]

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News